Literature DB >> 27923750

Affinity of Mucormycosis for Basal Ganglia in Intravenous Drug Users: Case Illustration and Review of Literature.

Ali Hazama1, Michael Galgano2, Joseph Fullmer3, Walter Hall2, Lawrence Chin2.   

Abstract

Central nervous system mucormycosis is an aggressive fungal infection often ending in fatality. The usual circumstance is an immunocompromised individual presenting with rapidly progressive rhinocerebral involvement. An extremely rare variant of central nervous system mucormycosis isolated to the basal ganglia in an immunocompetent intravenous drug user is detailed in this manuscript. The patient was aggressively treated with aspiration of the fungal abscess and long-term intravenous antifungal agents.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral fungal infection; Mucormycosis; Rhizopus

Mesh:

Substances:

Year:  2016        PMID: 27923750     DOI: 10.1016/j.wneu.2016.11.130

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Treatment of cerebral mucormycosis with drug therapy alone: A case report.

Authors:  Fatehi Elzein; Kiran Kalam; Nazik Mohammed; Ahmed Elzein; Fadhel Zaben Alotaibi; Mujtaba Khan; Abeer Albadani
Journal:  Med Mycol Case Rep       Date:  2018-10-28

Review 2.  Mucormycosis of the Central Nervous System.

Authors:  Amanda Chikley; Ronen Ben-Ami; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2019-07-08

3.  Isolated Cerebral Mucormycosis in Immunocompetent Adults who Inject Drugs: Case Reports and Systematic Review of the Literature.

Authors:  Eric A Meyerowitz; Sarimer Sanchez; Michael K Mansour; Virginia A Triant; Marcia B Goldberg
Journal:  Open Forum Infect Dis       Date:  2020-11-13       Impact factor: 3.835

4.  Case Report: Metagenomics Next-Generation Sequencing for Diagnosing Cerebral Infarction and Infection Caused by Hematogenous Disseminated Mucormycosis in a Patient With Acute Lymphoblastic Leukemia.

Authors:  Bingbing Wen; Lisheng Cai; Yun Cai; Xin Du
Journal:  Front Med (Lausanne)       Date:  2021-12-17

Review 5.  Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.

Authors:  Pavan Kumar Rudrabhatla; Aravind Reghukumar; Sanjeev V Thomas
Journal:  Acta Neurol Belg       Date:  2021-11-24       Impact factor: 2.471

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.